DASA Completes “Re-IPO” on the São Paulo Stock Exchange (B3)



Grenfel S. Calheiros Grenfel S. Calheiros
Luiz F. Noronha Luiz F. Noronha
Winnie Y. Loureiro Winnie Y. Loureiro

The Firm represented Diagnósticos da América S.A. (“DASA”) in connection with its “re-IPO” on the São Paulo Stock Exchange (B3) at a public offering price of R$58 per common share. The offering raised R$3.3 billion in gross proceeds (excluding the underwriters’ over-allotment option) to DASA.

The common shares were offered to certain institutional investors in Brazil, to qualified institutional buyers in the United States under Rule 144A, and to non-U.S. persons outside the United States in reliance upon Regulation S. DASA’s common shares are traded on the B3 under the ticker symbol “DASA3.”

DASA is a Brazilian health ecosystem, operating an integrated health network that provides a superior health experience to users every day by delivering high-quality healthcare services, focused on four pillars: people-centered ecosystem, diversity, learning and integrity.

The Simpson Thacher team included Grenfel S. Calheiros, Luiz F. Noronha, Winnie Y. Loureiro and Alexandre Portnoi (Capital Markets); and Kelli Rivers and Beatriz Capeloa Gil (Tax).

Team and Contacts